ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,237, issued on July 29, was assigned to RUPRECHT - KARLS - UNIVERSITAT HEIDELBERG (Heidelberg, Germany).
"Lipopeptides for use in treating liver diseases and cardiovascular diseases" was invented by Volker Cleeves (Weingarten, Germany), Stephan Urban (Neustadt/Weinstrasse, Germany) and Ralf Kubitz (Duesseldorf, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to lipopeptide-based compounds for use in the diagnosis, prevention and/or treatment of a liver disease or condition, preferably liver involved metabolic diseases, as well as in the control or modification of the cholesterol level or cholesterol uptake and, t...